S 5316 United States Senate · 117th Congress

Federal Clarity for Kratom Consumers Act

Summary
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2022
Committee Review
Floor Vote
President
Introduced Dec 20, 2022 Last action Dec 20, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Dec 20, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Dec 20, 2022
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor

Sponsors